News
NBSE
0.4199
+4.45%
0.0179
Weekly Report: what happened at NBSE last week (0408-0412)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Qilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. Allarity Therapeutics stock rose 18.09% and Galecto stock increased by 5.58%. PaxMedica stock declined by 8.0% during the session.
Benzinga · 5d ago
Weekly Report: what happened at NBSE last week (0401-0405)?
Weekly Report · 04/08 11:28
NeuBase Therapeutics Received A Notice On April 4, 2024 From The Listing Qualifications Department Of The Nasdaq Stock Market Notifying The Company That It Was Not In Compliance With Nasdaq's Continued Listing Requirements Under Nasdaq Listing Rule 5250(c)(1)
NeuBase Therapeutics, Inc. Received a notice on April 4, 2024 that it is not in compliance with Nasdaq's continued listing requirements. The Company failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 in a timely manner. This notice has no immediate effect on the listing of the Company's common stock on the Nasdaq.
Benzinga · 04/05 20:09
NEUBASE THERAPEUTICS ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ
Reuters · 04/05 20:06
Weekly Report: what happened at NBSE last week (0325-0329)?
Weekly Report · 04/01 11:25
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47. The company announced it is holding a Special Meeting of Stockholders on May 13, online. The meeting will be held to discuss and vote on the proposed liquidation and dissolution of the company.
Benzinga · 03/26 18:43
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Westport Fuel Systems Inc. (NASDAQ:WPRT) posts wider-than-expected fourth-quarter loss. Krispy Kreme, Inc. And McDonald's expanded their partnership. Stoke Therapeutics, Inc., shares gained 72.6% to $11.24. C3is Inc. Reported a year-over-year increase in financial results.
Benzinga · 03/26 17:45
12 Health Care Stocks Moving In Tuesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's, Q4 earnings came out 3 days ago. Mesoblast and OpGen shares also moved upwards.
Benzinga · 03/26 17:31
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% on Tuesday. U.S. Durable goods orders increased by 1.4% month-over-month in February. Consumer discretionary shares jumped by 0.7% on Monday. Asian markets closed mixed in Asia Pacific markets.
Benzinga · 03/26 14:09
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers
NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutic among healthcare movers. S&P 500 Health Care Sector +0.2% to 1697.44. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 03/26 14:00
Why Is AppTech Payments (APCX) Stock Down 41% Today?
AppTech Payments (NASDAQ:APCX) stock is falling on Tuesday after the financial technology company priced a public offering for its shares. APCX stock is down 41% as of Tuesday morning. The company is selling 2 million shares of its stock at a discounted price of $1 per share. Trump Media & Technology Group stock, NeuBase Therapeutics and Elbit Systems are also falling today.
Investorplace · 03/26 13:29
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners , Alibaba, McCormick
U.S. Stock index futures ticked up on Tuesday as most megacap and chip stocks advanced. Investors readied for more data to assess the Federal Reserve's rate path. Dow e-minis were up 0.10% at 39,739.25. The top three NYSE percentage gainers were Reddit, Alibaba and McCormick.
Reuters · 03/26 13:16
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
NeuBase Therapeutics (NASDAQ:NBSE) stock is falling on Tuesday after the company announced details for an upcoming special shareholder meeting. The company is seeking shareholder approval for the liquidation and dissolution of the company. Shares of NBSE stock are down 57.9% on Tuesday morning. More than 222,000 shares of the stock are changing hands as investors sell their stakes. We have all of the hottest stock market news on Tuesday.
Investorplace · 03/26 13:08
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The company's, Q4 earnings came out yesterday. OpGen shares moved upwards by 77.6% and Praxis Precision Medicine (PRAX) shares increased by 21.38%. ABVC BioPharma (ABVC) and Sutro Biopharma (STRO) were among the losers.
Benzinga · 03/26 13:05
GOEV, NBSE and FLGC among pre-market losers
GOEV, NBSE and FLGC among pre-market losers. NeuBase Therapeutics (NBSE) -58%. AppTech Payments Corp (APCX) announces proposed underwritten public offering. Bluebird bio (BLUE) reports Q4 results.
Seeking Alpha · 03/26 12:15
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Shares of Stoke Therapeutics, Inc. Rose sharply in today's pre-market trading. The company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Check-Cap Ltd. Shares gained 38.3% to $2.67 in pre- market trading. Krispy Kreme and McDonald's USA announced expanded national partnership.
Benzinga · 03/26 12:00
BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, UPS, Dell
U.S. Stock index futures ticked up on Tuesday. Most megacap and chip stocks advanced. Krispy Kreme, UPS, Dell and Newmont rise. Investors readied for more data to assess the Federal Reserve's rate path in a week curtailed by Easter break.
Reuters · 03/26 11:44
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Stoke Therapeutics stock is rocketing more than 81% alongside positive Phase 1/2a studies data. The biggest pre-market stock movers on Tuesday are pharmaceutical updates, earnings reports, collaboration agreements and more. Tidal Trust II YieldMax MRNA Option Income Strategy ETF (MRNY) stock is plummeting 60% this morning.
Investorplace · 03/26 11:36
12 Health Care Stocks Moving In Monday's After-Market Session
Stoke Therapeutics (NASDAQ:STOK) shares increased by 77.7% to $11.55 during Monday's after-market session. The company's market cap stands at $515.7 million. OpGen shares moved upwards by 66.61% as the Q4 earnings report came out today.
Benzinga · 03/25 21:32
More
Webull provides a variety of real-time NBSE stock news. You can receive the latest news about Neubase Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About NBSE
NeuBase Therapeutics, Inc. is a preclinical-stage biotechnology company. It is developing a modular peptide-nucleic acid (PNA) antisense oligo (PATrOL) platform to address genetic diseases, with a single, cohesive approach. The Company’s programs are NT-0100 in HD, NT-0200 in myotonic dystrophy type 1 (DM1) and NT-0300 in KRAS-driven cancers. The NT-0100 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the HD DNA or RNA. The NT-0200 program is a PATrOL-enabled therapeutic program being developed to target the mutant expansion in the DM1 disease RNA. The NT-0300 program is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene. It uses its platform to address diseases which have a genetic source, with an initial focus on gene silencing in DM1, Huntington’s disease (HD), and oncology and in gene editing applications. It also focused on identifying and evaluating multiple indications for potential development.